October 04, 2019
The federal government and dozens of states declined to join a whistleblower lawsuit accusing Allergan Inc. of concealing the health risks of its glaucoma medicine and subsequently collecting reimbursements from public insurance programs, according to documents unsealed Friday in Manhattan federal court.